A review of pregnancy and lactation postmarketing studies required by the FDA

J Krastein, L Sahin, L Yao - Pharmacoepidemiology and Drug …, 2023 - Wiley Online Library
Since pregnant and lactating women have historically been excluded from drug
development trials, safety studies need to be conducted postapproval. This study evaluated …
被引用次数：5 相关文章

A review of pregnancy and lactation postmarketing studies required by the FDA

J Krastein, L Sahin, L Yao - … and drug safety, 2023 - pubmed.ncbi.nlm.nih.gov
Since pregnant and lactating women have historically been excluded from drug
development trials, safety studies need to be conducted postapproval. This study evaluated …

A Review of Pregnancy and Lactation Postmarketing Studies Required by the FDA.

J Krastein, L Sahin, L Yao - Pharmacoepidemiology and Drug …, 2022 - europepmc.org
Since pregnant and lactating women have historically been excluded from drug
development trials, safety studies need to be conducted postapproval. This study evaluated …